BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis 2015;21:453-67. [PMID: 25248003 DOI: 10.1097/MIB.0000000000000209] [Cited by in Crossref: 53] [Cited by in F6Publishing: 28] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Xiong S, Whitehurst CE, Li L, Heo GS, Lai CW, Jain U, Muegge BD, Espenschied ST, Musich RJ, Chen M, Liu Y, Liu TC, Stappenbeck TS. Reverse translation approach generates a signature of penetrating fibrosis in Crohn's disease that is associated with anti-TNF response. Gut 2022;71:1289-301. [PMID: 34261752 DOI: 10.1136/gutjnl-2020-323405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Karaskova E, Kubickova V, Velganova-veghova M, Geryk M, Foltenova H, Karasek D. Circulating Levels of WISP-1 (Wnt1-Inducible Signaling Pathway Protein 1) and Other Selected Adipokines in Children With Inflammatory Bowel Disease. Physiol Res 2022. [DOI: 10.33549/physiolres.934854] [Reference Citation Analysis]
3 Turri G, Carvello M, Ben David N, Spinelli A. Intriguing Role of the Mesentery in Ileocolic Crohn's Disease. Clin Colon Rectal Surg. [DOI: 10.1055/s-0042-1743590] [Reference Citation Analysis]
4 Wu X, Mu Y, Yao J, Lin F, Wu D, Ma Z. Adipose-Derived Stem Cells From Patients With Ulcerative Colitis Exhibit Impaired Immunosuppressive Function. Front Cell Dev Biol 2022;10:822772. [DOI: 10.3389/fcell.2022.822772] [Reference Citation Analysis]
5 Murad H, Rafeeq M, Mosli M, Gari M, Basheikh M. Effect of sequential eradication therapy on serum osteoprotegerin levels in patients with Helicobacter pylori infection and co-existing inflammatory bowel disease. J Int Med Res 2021;49:3000605211060648. [PMID: 34851775 DOI: 10.1177/03000605211060648] [Reference Citation Analysis]
6 Papaefthymiou A, Potamianos S, Goulas A, Doulberis M, Kountouras J, Polyzos SA. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. J Crohns Colitis 2021:jjab212. [PMID: 34972203 DOI: 10.1093/ecco-jcc/jjab212] [Reference Citation Analysis]
7 Moran MM, Wessman P, Rolfson O, Bohl DD, Kärrholm J, Keshavarzian A, Sumner DR. The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study. PLoS One 2021;16:e0257310. [PMID: 34735461 DOI: 10.1371/journal.pone.0257310] [Reference Citation Analysis]
8 Wu ZX, Wang F, Li L, Yao Y, Long J, Luo QQ, Zhao ZB, Li WL, Cao J, Lian ZX. The Clinical Significance of Mesenteric Lymphocytes in Human Colorectal Cancer. Front Oncol 2021;11:685577. [PMID: 34604029 DOI: 10.3389/fonc.2021.685577] [Reference Citation Analysis]
9 Han ZM, Chen BX, Zhou Q, Liu HB, Xu PC, Zhi FC. Predictors of infliximab-induced deep remission in treatment-naïve patients with isolated small bowel Crohn's disease. Scand J Gastroenterol 2021;56:1422-6. [PMID: 34461786 DOI: 10.1080/00365521.2021.1971759] [Reference Citation Analysis]
10 O’grady J, Shanahan F, Bronte F. Changing phenotype of inflammatory bowel disease and neglected metabolic health. Cogent Medicine 2021;8:1918318. [DOI: 10.1080/2331205x.2021.1918318] [Reference Citation Analysis]
11 Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of Adipose Tissue in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:4226. [PMID: 33921758 DOI: 10.3390/ijms22084226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dhaliwal A, Quinlan JI, Overthrow K, Greig C, Lord JM, Armstrong MJ, Cooper SC. Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview. Nutrients 2021;13:656. [PMID: 33671473 DOI: 10.3390/nu13020656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Kurashima Y, Kigoshi T, Murasaki S, Arai F, Shimada K, Seki N, Kim YG, Hase K, Ohno H, Kawano K, Ashida H, Suzuki T, Morimoto M, Saito Y, Sasou A, Goda Y, Yuki Y, Inagaki Y, Iijima H, Suda W, Hattori M, Kiyono H. Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation. Nat Commun 2021;12:1067. [PMID: 33594081 DOI: 10.1038/s41467-021-21277-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Danielak A, Wojcik D, Mazur-Bialy A, Surmiak M, Bilski J, Targosz A, Magierowski M, Chmura A, Strzalka M, Krzysiek-Maczka G, Magierowska K, Szczyrk U, Kwiecien S, Ptak-Belowska A, Brzozowski T. Intestinal Alkaline Phosphatase Combined with Voluntary Physical Activity Alleviates Experimental Colitis in Obese Mice. Involvement of Oxidative Stress, Myokines, Adipokines and Proinflammatory Biomarkers. Antioxidants (Basel) 2021;10:240. [PMID: 33557311 DOI: 10.3390/antiox10020240] [Reference Citation Analysis]
15 Rodríguez-Benítez MV, Gámez-Belmonte R, Gil-Campos M, Hernández-Chirlaque C, Bouzas PR, Sánchez de Medina F, Martínez-Augustin O. Premature Birth Infants Present Elevated Inflammatory Markers in the Meconium. Front Pediatr 2020;8:627475. [PMID: 33537270 DOI: 10.3389/fped.2020.627475] [Reference Citation Analysis]
16 Serena C, Queipo-Ortuño M, Millan M, Sanchez-Alcoholado L, Caro A, Espina B, Menacho M, Bautista M, Monfort-Ferré D, Terrón-Puig M, Núñez-Roa C, Maymó-Masip E, Rodriguez MM, Tinahones FJ, Espin E, Martí M, Fernández-Veledo S, Vendrell J. Microbial Signature in Adipose Tissue of Crohn's Disease Patients. J Clin Med 2020;9:E2448. [PMID: 32751800 DOI: 10.3390/jcm9082448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Agliata I, Fernandez-Jimenez N, Goldsmith C, Marie JC, Bilbao JR, Dante R, Hernandez-Vargas H. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells. Epigenetics 2020;15:1068-82. [PMID: 32281463 DOI: 10.1080/15592294.2020.1748916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Sáez-González E, Mateos B, López-Muñoz P, Iborra M, Moret I, Nos P, Beltrán B. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.Nutrients. 2019;11:1062. [PMID: 31083616 DOI: 10.3390/nu11051062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
19 Stephens M, Liao S, von der Weid PY. Mesenteric Lymphatic Alterations Observed During DSS Induced Intestinal Inflammation Are Driven in a TLR4-PAMP/DAMP Discriminative Manner. Front Immunol 2019;10:557. [PMID: 30972059 DOI: 10.3389/fimmu.2019.00557] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
20 Hudson JL, Barnes EL, Herfarth HH, Isaacs KL, Jain A. Bariatric Surgery Is a Safe and Effective Option for Patients with Inflammatory Bowel Diseases: A Case Series and Systematic Review of the Literature. Inflamm Intest Dis 2019;3:173-9. [PMID: 31111033 DOI: 10.1159/000496925] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
21 Magro DO, Cazzo E, Kotze PG, Vasques ACJ, Martinez CAR, Chaim EA, Geloneze B, Pareja JC, Coy CSR. Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery. Obes Surg 2018;28:378-88. [PMID: 28776152 DOI: 10.1007/s11695-017-2851-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Serena C, Keiran N, Madeira A, Maymó-Masip E, Ejarque M, Terrón-Puig M, Espin E, Martí M, Borruel N, Guarner F, Menacho M, Zorzano A, Millan M, Fernández-Veledo S, Vendrell J. Crohn's Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation. Stem Cell Reports 2017;9:1109-23. [PMID: 28966116 DOI: 10.1016/j.stemcr.2017.07.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
23 Takahashi Y, Sato S, Kurashima Y, Lai CY, Otsu M, Hayashi M, Yamaguchi T, Kiyono H. Reciprocal Inflammatory Signaling Between Intestinal Epithelial Cells and Adipocytes in the Absence of Immune Cells. EBioMedicine. 2017;23:34-45. [PMID: 28789943 DOI: 10.1016/j.ebiom.2017.07.027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
24 Scaldaferri F, Pizzoferrato M, Lopetuso LR, Musca T, Ingravalle F, Sicignano LL, Mentella M, Miggiano G, Mele MC, Gaetani E, Graziani C, Petito V, Cammarota G, Marzetti E, Martone A, Landi F, Gasbarrini A. Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract. 2017;2017:8646495. [PMID: 28127306 DOI: 10.1155/2017/8646495] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 16.0] [Reference Citation Analysis]
25 Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, Mjösberg J, Ruhrmann S, Fabbri A, Vukojevic V, Percipalle P, Salomons FA, Laurencikiene J, Törkvist L, Halfvarson J, D'Amato M. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS One 2016;11:e0168276. [PMID: 27959965 DOI: 10.1371/journal.pone.0168276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
26 Moran C, Sheehan D, Shanahan F. The Changing Phenotype of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:1619053. [PMID: 28050166 DOI: 10.1155/2016/1619053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
27 Karrasch T, Schaeffler A. Adipokines and the role of visceral adipose tissue in inflammatory bowel disease. Ann Gastroenterol 2016;29:424-38. [PMID: 27708507 DOI: 10.20524/aog.2016.0077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
28 Lochhead P, Khalili H, Ananthakrishnan AN, Richter JM, Chan AT. Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016;14:818-824.e6. [PMID: 26844874 DOI: 10.1016/j.cgh.2016.01.016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]